Book a Demo
Menu
Login

Who we are

We're a team of passionate individuals from diverse backgrounds that are dedicated to helping patients access the information they need to lower their cancer risk. 

What we do

In the fight against cancer, genes are key. Genetic tests, along with a patient’s lifestyle markers (diet, exercise, smoking), can clearly signal when pre-emptive strategies should be implemented. But unless genetic services can be made more practical, physicians often skip the process altogether.

CancerIQ's "cancer risk clinic in a box" makes it faster and less expensive for physicians to identify high-risk patients and navigate them towards services that can pre-empt or prevent cancer. By automating the most time-consuming admin tasks that keep community-based physicians from offering genetic services, we improve patient access to life-saving medical care. Our product suite contains predictive analytics and screening tools to identify at-risk patients; clinical guidance with proven outcomes; a digital genetic test ordering platform and patient management and education tools.

Meet the Leadership Team

Act2 Sample Image

Feyi Olopade Ayodele, MBA

Co-Founder, Chief Executive Officer

Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse respectively...

Continue

Act2 Sample Image

Haibo Lu, MBA

Co-Founder, VP of Product and Customer Success

Haibo received his Bachelor’s in Economics and Psychology at Harvard University and his MBA from the University of Chicago Booth School of Business.... 

Continue

Act2 Sample Image

Olufunmilayo (Funmi) Olopade, MD

Co-Founder, Chief Scientific Advisor

Dr. Olopade is a medical oncologist and Founder of the Clinical Cancer Genetics Program at the University of Chicago Medicine...

Continue

Act2 Sample Image

Christopher Bun, PhD

Chief Technology Officer

Chris has a Bachelor’s and Masters in Computer Science from Loyola, and his PhD from the University of Chicago...

Continue